V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 190008856 | 190002491 | null | null | null | null | 2017-07-20 | PAM x 2 pre-surgery (cycles 1&2) | null | null | CISPLATIN + DOXORUBICIN + METHOTREXATE | 100851357 |
| 190008859 | 190002492 | 1.76 | 58.6 | Palliative (P) | 2019-02-09 | 2019-02-28 | CAPECITABINE + OXALIPLATIN | 02 | N | CISPLATIN + ETOPOSIDE + METHOTREXATE | 101563739 |
| 190008862 | 190002493 | null | null | null | null | 2016-09-26 | Doxorubicin 75mg/m2 | null | null | CARBOPLATIN + ETOPOSIDE | 101179378 |
| 190008863 | 190002494 | 0 | 33.4 | Curative (C) | 2020-01-14 | 2020-01-21 | Cisplatin + Doxorubicin | N | N | CISPLATIN + DOXORUBICIN | 101535581 |
| 190008866 | 190002495 | null | null | null | null | 2019-04-23 | Carboplatin + Paclitaxel (3 weekly) | null | null | DOXORUBICIN + METHOTREXATE | 101097471 |
| 190008872 | 190002497 | null | null | null | null | 2017-10-11 | MAP | null | null | CISPLATIN + DOXORUBICIN + METHOTREXATE | 101167052 |
| 190008876 | 190002498 | null | null | null | null | 2019-08-07 | Cisplatin + Doxorubicin | null | null | CISPLATIN + DOXORUBICIN | 100006013 |
| 190008881 | 190002499 | null | null | null | null | 2019-11-23 | CAP | null | null | NOT MATCHED | 100459149 |
| 190008891 | 190002503 | null | null | null | null | 2017-09-15 | OST Euramos 1 Closed Trial - AP | null | null | OST AP | 101394510 |
| 190008894 | 190002504 | null | null | null | null | 2018-02-20 | MAP | null | null | CISPLATIN + DOXORUBICIN + METHOTREXATE | 100552932 |
| 190008898 | 190002506 | 1.7 | 61.4 | Neo-adjuvant (N) | 2019-04-18 | 2019-05-01 | Carboplatin AUC 2 - 5 | 02 | N | CARBOPLATIN + PACLITAXEL | 100932013 |
| 190008903 | 190002507 | null | null | 03 | null | 2017-12-27 | Enzalutamide | null | null | EW EUROEWING 2012 ARM A VIDE | 100569937 |
| 190008909 | 190002508 | null | null | null | null | 2020-01-08 | OCTREOTIDE | null | null | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 100432719 |
| 190008915 | 190002510 | 1.7 | 105 | Palliative (P) | 2016-03-17 | 2016-03-22 | GemCarbo Days 1+8 | 02 | N | CAPECITABINE + CARBOPLATIN | 100328875 |
| 190008917 | 190002512 | null | null | null | 2018-07-14 | 2018-07-14 | OST Euramos 1 Closed Trial - AP | null | null | OST AP | 101115803 |
| 190008919 | 190002513 | null | null | null | null | 2017-01-08 | OST Euramos 1 Closed Trial - Ai | null | null | DOXORUBICIN + METHOTREXATE | 100618596 |
| 190008925 | 190002515 | 1.7 | 79.8 | Disease modification (D) | 2019-07-20 | 2019-07-20 | PAM x 2 pre-surgery (cycles 1&2) | 02 | N | CISPLATIN + DOXORUBICIN + METHOTREXATE | 100709552 |
| 190008926 | 190002516 | 1.7 | 77 | Curative (C) | null | 2019-08-30 | FLUOROURACIL + OXALIPLATIN | 02 | null | DOXORUBICIN | 100593261 |
| 190008930 | 190002517 | 1.67 | 48.75 | Curative (C) | 2017-07-10 | 2017-07-10 | ECX | 02 | N | MAP | 101427877 |
| 190008933 | 190002518 | 1.64 | 77.5 | Curative (C) | 2017-02-17 | 2017-02-25 | OST Euramos 1 Closed Trial - AP | 02 | Y | OST AP | 100814170 |
| 190008934 | 190002519 | null | null | null | null | 2017-05-27 | IMATINIB | null | null | MIFAMURTIDE | 101206190 |
| 190008936 | 190002520 | 1.65 | 37.4 | Curative (C) | 2017-07-11 | 2017-08-01 | GemCarbo Days 1+8 | 01 | null | CAPECITABINE | 101095957 |
| 190008945 | 190002522 | 0 | 38.8 | Palliative (P) | 2019-09-07 | 2019-09-15 | OST Euramos 1 Closed Trial - AP | Y | N | OST AP | 100559012 |
| 190008946 | 190002523 | null | null | null | null | 2016-11-11 | EOX | null | null | DOXORUBICIN + ETOPOSIDE + IFOSFAMIDE + VINCRISTINE | 100564864 |
| 190008949 | 190002524 | 1.69 | 60.4 | Palliative (P) | 2017-04-07 | 2017-04-23 | CARBOPLATIN | 2 | N | TRIAL | 101798639 |
| 190008958 | 190002526 | 1.74 | 78.5 | Curative (C) | 2017-06-01 | 2017-06-08 | EW EuroEwing 2012 Arm B VDC | 02 | N | EW EUROEWING 2012 ARM B VDC | 101393626 |
| 190008962 | 190002527 | 1.77 | 96.4 | Palliative (P) | 2019-11-29 | 2019-12-04 | null | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 101803456 |
| 190008964 | 190002529 | 1.57 | 104.8 | Palliative (P) | 2019-06-29 | 2019-07-21 | Cisplatin + Etoposide (3 day) | 02 | N | METHOTREXATE HIGH DOSE | 101529840 |
| 190008968 | 190002530 | null | null | null | null | 2018-09-10 | Cisplatin + Doxorubicin | null | null | CISPLATIN + DOXORUBICIN | 100672208 |
| 190008969 | 190002531 | null | null | null | null | 2020-07-23 | Dox + HD Mtx (post PAM) | null | null | MAP | 101317787 |
| 190008971 | 190002533 | 1.5 | 43.6 | Curative (C) | 2019-12-28 | 2020-01-03 | OCTREOTIDE | 02 | N | VIDE | 100299477 |
| 190008974 | 190002534 | 1.75 | 55.9 | null | null | null | Capecitabine + Oxaliplatin 21day | 02 | null | EURAMOS TRIAL | 101788134 |
| 190008975 | 190002535 | 1.83 | 79.2 | null | 2018-08-28 | 2018-08-29 | BEP 3 day | N | null | MAP | 101319053 |
| 190008977 | 190002536 | 1.59 | 86 | Neo-adjuvant (N) | 2018-03-18 | 2018-04-12 | CARBOPLATIN + GEMCITABINE | 02 | N | ABIRATERONE | 100148590 |
| 190008986 | 190002538 | null | null | null | null | 2019-12-11 | Capecitabine + Oxaliplatin 21day | null | null | MAP | 101100381 |
| 190008992 | 190002540 | null | null | null | null | 2018-09-17 | EW EuroEwing 2012 Arm A VIDE | null | null | DOXORUBICIN + HD MTX | 100088471 |
| 190008994 | 190002541 | null | null | null | null | 2017-12-09 | OST Euramos 1 Closed Trial - AP | null | null | OST AP | 101583290 |
| 190008996 | 190002542 | 1.6 | 74 | Adjuvant (A) | 2018-04-11 | 2018-04-11 | Irinotecan + Modified De Gramont | 02 | N | ETOPOSIDE + IFOSFAMIDE | 100379288 |
| 190009001 | 190002543 | 1.61 | 71 | Curative (C) | 2019-05-26 | 2019-06-15 | GemCarbo Days 1+8 | 02 | N | EW EUROEWING 99 : VIDE | 100546701 |
| 190009008 | 190002546 | 1.88 | 67.6 | Adjuvant (A) | 2018-01-17 | 2018-01-25 | EOX | 02 | Y | DOXORUBICIN + METHOTREXATE | 100874159 |
| 190009011 | 190002547 | 1.67 | null | Palliative (P) | 2017-01-27 | 2017-01-27 | EURAMOS TRIAL | 2 | N | CAPECITABINE | 100810051 |
| 190009013 | 190002548 | null | null | null | null | 2016-03-06 | OST Euramos 1 Closed Trial - AP | null | null | OST AP | 101584192 |
| 190009022 | 190002552 | 1.61 | 62.8 | Palliative (P) | 2019-03-23 | 2019-04-06 | OST Euramos 1 Closed Trial - AP | 2 | N | OST AP | 100629178 |
| 190009023 | 190002553 | null | null | null | null | 2016-12-04 | Cisplatin + Doxorubicin | null | null | CISPLATIN + DOXORUBICIN | 101638697 |
| 190009029 | 190002555 | 1.47 | 78.5 | Curative (C) | 2017-01-05 | 2017-01-25 | Docetaxel 75mg/m2 (21 day) | 02 | Y | DOXORUBICIN + IFOSFAMIDE | 100432074 |
| 190009031 | 190002557 | null | null | null | null | 2019-06-30 | Cisplatin + Doxorubicin | null | null | CISPLATIN + DOXORUBICIN | 100211955 |
| 190009034 | 190002558 | 1.6 | 95 | Neo-adjuvant (N) | 2016-05-04 | 2016-05-04 | Cisplatin + Etoposide (3 day) | null | null | DOXORUBICIN | 100049352 |
| 190009035 | 190002559 | null | null | null | null | 2016-03-17 | Trial Unspecified | null | null | MAP | 100827071 |
| 190009042 | 190002561 | 1.65 | 80.4 | null | 2016-06-30 | 2016-07-08 | GEMCARBO | 02 | N | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 100494068 |
| 190009047 | 190002563 | 1.55 | 52.4 | Palliative (P) | 2017-03-03 | 2017-03-22 | Cisplatin + Radiotherapy | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101648924 |